Yayıncı "MDPI" Diğer Yayınlar Koleksiyonu için listeleme
Toplam kayıt 7, listelenen: 1-7
-
Circadian dysfunction in adipose tissue: Chronotherapy in metabolic diseases
(MDPI, 2023)Essential for survival and reproduction, the circadian timing system (CTS) regulates adaptation to cyclical changes such as the light/dark cycle, temperature change, and food availability. The regulation of energy homeostasis ... -
Current approaches to the treatment of gastric varices: Glue, coil application, TIPS, and BRTO
(MDPI, 2019)Gastric varices are less common than esophageal varices, and their treatment is quite challenging. Gastric varix bleedings (GVB) occur less frequently than esophageal varix (EV) bleedings and represent 10% to 30% of all ... -
Diagnosis of periprosthetic joint infection: The utility of biomarkers in 2023
(MDPI, 2023)Periprosthetic joint infection (PJI) is a rare yet devastating complication following total joint arthroplasty (TJA). Early and accurate diagnosis of PJI is paramount in order to maximize the chances of successful treatment. ... -
How telemedicine can improve the quality of care for patients with alzheimer’s disease and related dementias? A narrative review
(MDPI, 2022)Background and Objectives: Dementia affects more than 55 million patients worldwide, with a significant societal, economic, and psychological impact. However, many patients with Alzheimer’s disease (AD) and other related ... -
Mobile health in urology: The good, the bad and the ugly
(MDPI, 2020)Our aim is to present the current position of mobile health (mHealth) and the delivery of healthcare services via mobile communication devices in urology. We conducted a literature review of urology mHealth papers on PubMed. ... -
Nanodrugs for the treatment of ischemic stroke: A systematic review
(MDPI, 2023)Ischemic stroke, a significant neurovascular disorder, currently lacks effective restorative medication. However, recently developed nanomedicines bring renewed promise for alleviating ischemia’s effects and facilitating ... -
Protein and gene delivery systems for neurodegenerative disorders: Where do we stand today?
(MDPI, 2022)It has been estimated that every year, millions of people are affected by neurodegenerative disorders, which complicate their lives and their caregivers’ lives. To date, there has not been an approved pharmacological ...